04:22 AM EST, 11/11/2025 (MT Newswires) -- Vor Biopharma ( VOR ) said late Monday it priced a public offering of 10 million common shares at $10 apiece, for roughly $100 million in expected gross proceeds.

Underwriters have a 30-day overallotment option to buy up to 1.5 million additional shares.

The company expects the offering to close by Wednesday.

Vor Biopharma ( VOR ) shares were down 28% in recent premarket activity Tuesday.